MenuSearch

Subscribe today and save 57%

Investors Chronicle print and digital editions

Full Year Results

Full Year Results 

Bioventix looks to next growth phase

The antibody developer believes its troponin assays will drive future momentum

Bioventix looks to next growth phase

Full Year Results 

River and Mercantile hindered by timing

River and Mercantile hindered by timing

Full Year Results 

Data drives progress in Sensyne’s first year

Data drives progress in Sensyne’s first year

Full Year Results 

YouGov benefits from real-time data

YouGov benefits from real-time data

Full Year Results 

Kin and Carta buoyed by innovation arm

Kin and Carta buoyed by innovation arm
Load more…

Most read today

  1. Stock Screens 

    10 red hot stocks

  2. Simon Thompson 

    Profit from green energy

  3. Today's Market Overview 

    News & Tips: Reckitt Benckiser, Whitbread, Just Eat & more

  4. Today's Market Overview 

    News & Tips: Smith & Nephew, Funding Circle, JustEat & more

  5. Simon Thompson 

    Marriott’s Elegant acquisition

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now